e-learning
resources
London 2016
Monday, 05.09.2016
ILD pathogenesis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis
Masaki Tominaga (Kurume, Japan), Masaki Tominaga, Masaki Okamoto, Takashi Kinoshita, Yuki Sakazaki, Masanobu Matsuoka, Shinjiro Kaieda, Tomoaki Hoshino
Source:
International Congress 2016 – ILD pathogenesis
Session:
ILD pathogenesis
Session type:
Poster Discussion
Number:
3088
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Masaki Tominaga (Kurume, Japan), Masaki Tominaga, Masaki Okamoto, Takashi Kinoshita, Yuki Sakazaki, Masanobu Matsuoka, Shinjiro Kaieda, Tomoaki Hoshino. New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 3088
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
LATE-BREAKING ABSTRACT: The metalloproteinase ADAM8 promotes acute and chronic lung inflammation
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
A mouse model of acute lung injury implicates phospholipase Cε in neutrophilic inflammation through CXC chemokine production
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
TNF and IP-10 drive inflammation into hyperinflammation in the murine lung
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Effects of ceramide pathway inhibition on the inflammatory response in lipopolysacharide-triggered lung injury
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Preventive and therapeutic treatment with a7 nicotinic receptor agonist reduced lung inflammation and collagen deposition in mice with acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Heparin effect in alveolar cells and macrophages in an acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
ATP selectively packages TNF within microvesicles released from alveolar macrophages
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI)
Source: International Congress 2014 – ILDs 6
Year: 2014
Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Hypoxic challenge testing in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone
Source: International Congress 2014 – ILDs 1
Year: 2014
Circulating monocytes from interstitial lung disease patients show an activated phenotype
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Effects of VAChT reduction on the time course of lung inflammation in mice with acute lung injury
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept